19 December 2019 | News
Kakehashi, established in 2016 is developing medication instruction and medication history support software for pharmacies represented by the electronic drug history system “Musubi”
Japan based PHC Corporation has announced it was taking a stake in KAKEHASHI Inc., based on a share purchase agreement with the company.
Kakehashi developed Musubi, a next-generation electronic medication history system and conducts sales for this product in Japan. It is capable of automatically generating ideal medication adherence instructions that have been analyzed from varied information such as patient diseases, medications, lifestyles and other individual profiles, and the instruction is saved to the system as medication history. PHC signed a sales partnership agreement on October 9 for Kakehashi to sell PHC’s healthcare IT solution Pharnes and for the two companies to enhance system linkage between Pharnes and Musubi. This will promote the workflow improvement at pharmacies in Japan.
PHC is a global healthcare company offering products and services in diagnostics including diabetes, life sciences, and healthcare IT. Based on the mid-to-long-term partnership with Kakehashi through this investment, PHC will expedite discussion for developing the next-generation pharmacy system combining the knowhow and technologies of the two companies, while further enhancing Pharnes and Musubi linkage. PHC will work to realize a game-changing solution to provide appropriate medication adherence instructions for patients and further streamline pharmacist workflow. The investment will also become a catalyst for PHC for moving forward in building the next-generation healthcare platform, with open innovation through partnerships with other companies.
Takayuki Otsuka, member of the board and director of the Medical Information Systems (Medicom*) Division of PHC says, “Since launching Japan’s first medical-receipt computer in 1972, PHC has been the leading provider of medical IT products in the medical history information system field, using its accumulated experience and expertise. By strengthening our collaboration with Kakehashi specializing in medical application development, I believe we can respond faster to the needs of the health professionals and expand our product lineup to deliver better medical service for patients. Going forward, we will contribute to higher-quality medical care by providing easier-to-use digital solutions through new initiatives in partnering with other companies, including investments, and predicting medical environment and needs as a next-generation healthcare platformer."